Position in DNLI
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$5,957,883
+$1,047,176 QoQ
Shares Held
231,644
-9.4% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#56
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. DNLI ranks #39 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,957,883 | 231,644 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $4,910,707 | 255,766 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,603,659 | 339,410 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $5,729,592 | 394,600 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,943,097 | 496,290 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $4,195,145 | 308,580 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $5,416,025 | 265,752 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $7,123,799 | 244,552 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $4,159,909 | 179,152 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $3,516,840 | 171,386 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,953,804 | 91,044 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,785,050 | 135,000 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $2,491,293 | 84,422 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,034,938 | 88,322 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,759,002 | 99,209 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,888,634 | 94,123 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $3,567,592 | 121,223 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $4,279,800 | 133,037 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $5,456,230 | 122,337 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,398,926 | 126,837 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $9,949,094 | 126,837 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $8,041,792 | 140,837 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $11,209,098 | 133,824 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,545,163 | 98,944 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,392,937 | 57,607 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $572,699 | 32,707 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||